Background & Aims The increasing rates of obesity and type 2 diabetes mellitus may lead to
increased prevalence of nonalcoholic fatty liver disease (NAFLD). We aimed to determine …

Background Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease
worldwide and the leading cause of liver-related morbidity and mortality. We aimed to …

Background The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing. We
aimed to estimate the pooled global NAFLD incidence. Methods We performed a systematic …

Background Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver
disease worldwide. Asia is a large, heterogeneous area with substantial variation in …

Context Nonalcoholic fatty liver disease (NAFLD) prevalence is high, especially in patients
with obesity and type 2 diabetes, and is expected to rise steeply in the coming decades …

Background The prevalence of non‐alcoholic fatty liver disease (NAFLD) is increasing in
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …

Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …

Background: The increasing burden of non-alcoholic fatty liver disease (NAFLD) worldwide
imposes an emerging public health issue. We perform the current study to estimate the …

With rapid lifestyle transitions, the increasing burden of nonalcoholic fatty liver disease
(NAFLD) in China has emerged as a major public health issue. To obtain a comprehensive …

On 'International NASH Day', we launch a call for the global health community to
collaboratively shape and deliver a comprehensive, long-term public health agenda for …